MyFinsight
Home
Blog
About
Back
Income Statement
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)
source: myfinsight.com
Foreign currency
translation
$22,747
Comprehensive loss
-$11,543,918
Total other
comprehensive income
$13,084
Unrealized (loss) gains on
available-for-sale securities
-$9,663
Net loss
-$11,557,002
Interest income
$913,663
Loss before
provision for income taxes
-$11,542,680
Provision for income taxes
$14,322
Total other income,
net
$913,663
Loss from operations
-$12,456,343
Total operating
expenses
$12,456,343
General and
administrative expenses
$7,123,171
Research and development
$5,333,172
Back